Your browser doesn't support javascript.
loading
Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.
Perera, Marlon; El Khoury, John; Chinni, Vidyasagar; Bolton, Damien; Qu, Liang; Johnson, Paul; Trubiano, Jason; McDonald, Christine F; Jones, Daryl; Bellomo, Rinaldo; Patel, Oneel; Ischia, Joseph.
Affiliation
  • Perera M; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia marlonlperera@gmail.com.
  • El Khoury J; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
  • Chinni V; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
  • Bolton D; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
  • Qu L; Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
  • Johnson P; Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
  • Trubiano J; Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
  • McDonald CF; Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
  • Jones D; Intensive Care Unit Austin Hospital, Austin Health, Heidelberg, Victoria, Australia.
  • Bellomo R; Department of Medicine, Austin Health, Heidelberg, Victoria, Australia.
  • Patel O; Intensive Care Unit Austin Hospital, Austin Health, Heidelberg, Victoria, Australia.
  • Ischia J; Department of Medicine, Austin Health, Heidelberg, Victoria, Australia.
BMJ Open ; 10(12): e040580, 2020 Dec 02.
Article in En | MEDLINE | ID: mdl-33268419

Full text: 1 Database: MEDLINE Main subject: Zinc / COVID-19 Drug Treatment Type of study: Clinical_trials / Guideline Language: En Journal: BMJ Open Year: 2020 Type: Article Affiliation country: Australia

Full text: 1 Database: MEDLINE Main subject: Zinc / COVID-19 Drug Treatment Type of study: Clinical_trials / Guideline Language: En Journal: BMJ Open Year: 2020 Type: Article Affiliation country: Australia